Evidence map›Paper›PMID 37242434›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

Antioxidant Activity of Coumarins and Their Metal Complexes.

Lozan Todorov, Luciano Saso, Irena Kostova

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Advancing the Potential ofPlants (Basel, Switzerland) · 2026
    Article
  5. ACS omega · 2026
    Article
  6. Dual Evaluation ofJournal of clinical medicine · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Investigating Amphoteric 3,4'-Biscoumarin-BasedInternational journal of molecular sciences · 2025
    Article
  12. Review
  13. Article
  14. Advanced Research on Biological Properties-A Study on the Activity of theInternational journal of molecular sciences · 2025
    Article
  15. Pharmaco-Toxicological Effects ofAntioxidants (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Synthesis and structure of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lozan TodorovDepartment of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-7230-8368
Luciano SasoDepartment of Physiology and Pharmacology "Vittorio Erspamer", Faculty of Pharmacy and Medicine, Sapienza University, 00185 Rome, Italy.ORCID 0000-0003-4530-8706
Irena KostovaDepartment of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0001-6290-7327
Medical University of Sofia · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitously present in plant life, coumarins, as a class of phenolic compounds, have multiple applications-in everyday life, in organic synthesis, in medicine and many others. Coumarins are well known for their broad spectrum of physiological effects. The specific structure of the coumarin scaffold involves a conjugated system with excellent charge and electron transport properties. The antioxidant activity of natural coumarins has been a subject of intense study for at least two decades. Significant research into the antioxidant behavior of natural/semi-synthetic coumarins and their complexes has been carried out and published in scientific literature. The authors of this review have noted that, during the past five years, research efforts seem to have been focused on the synthesis and examination of synthetic coumarin derivatives with the aim to produce potential drugs with enhanced, modified or entirely novel effects. As many pathologies are associated with oxidative stress, coumarin-based compounds could be excellent candidates for novel medicinal molecules. The present review aims to inform the reader on some prominent results from investigations into the antioxidant properties of novel coumarin compounds over the past five years.

Indexed as

antioxidantantioxidant assayscoordination compoundscoumarinsmolecular hybridsradicals’ scavenging

Identifiers

PMID37242434
PMCPMC10220850
OpenAlexW4367183199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.